Last reviewed · How we verify
NCT06266351
EVALUATION of CATS TONOMETER PRISM in LASIK SUBJECTS
trial testing This is observational IOP measurement in Glaucoma in 198 participants. Completed in 1 August 2024.
1 July 2024
Quick facts
| Lead sponsor | Intuor Technologies, Inc. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 198 |
| Start date | 12 February 2024 |
| Primary completion | 1 July 2024 |
| Estimated completion | 1 August 2024 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- This is observational IOP measurement
Conditions studied
- Glaucoma — all drugs for Glaucoma →
- Ocular Hypertension — all drugs for Ocular Hypertension →
- Normal Tension Glaucoma — all drugs for Normal Tension Glaucoma →
Sponsor
Intuor Technologies, Inc. — full company profile →
Who can join
22 and older, any sex, with Glaucoma or Ocular Hypertension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The CATS Tonometer prism clinical study is intended to determine repeatability of intraocular pressure measurement in human corneas which have undergone a LASIK procedure when compared to a standard Goldmann prism, validating the human LASIK eye findings comparing CATS Tonometer and Goldmann prisms to intracameral pressure in cadaver eyes.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Intraocular Pressure Accuracy Post-Myopic Laser in situ Keratomileusis: Pivotal Study Results, Standard vs Correcting Applanation Tonometry Surface Goldmann Tonometry.
Kilgore KP, McCafferty S, Levine J. · · 2026 · PMID 41858980 · DOI 10.2147/opth.s567942
Verify or expand the search:
- PubMed search for NCT06266351
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Glaucoma
Currently open trials in the same condition.
- NCT07455786 — Modified Trabeculectomy After Failure of Combined Phaco With GATT · NA · recruiting
- NCT07298356 — Automated Applanation Tonometry - Updated · NA · recruiting
- NCT07217678 — Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use · Phase 4 · recruiting
- NCT07145073 — Repetitive Transcranial Alternating Current Stimulation (rtACS) for the Treatment of Optic Neuropathies · NA · recruiting
- NCT07209410 — Evaluating Injection With the Use of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanopro · Phase 4 · recruiting
Other Intuor Technologies, Inc. trials
Trials by the same sponsor.
- NCT04180111 — Cross Linking Corneal Biomechanical Evaluation of CATS Tonometer Prism · unknown
- NCT04178863 — CATS Tonometer IOP Reduction Latanoprost Verses Timolol · Phase 4 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06266351 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Intuor Technologies, Inc.
- Last refreshed: 5 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06266351.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing